EPRX
EUPRAXIA PHARMACEUTICALS INC.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 6-K | 9/30/2026 | View on SEC |
| 6-K | 9/8/2026 | View on SEC |
| SUPPL | 9/2/2026 | View on SEC |
| EFFECT | 8/24/2026 | View on SEC |
| F-10/A | 8/19/2026 | View on SEC |
| SCHEDULE 13G/A | 8/13/2026 | View on SEC |
| 6-K | 8/13/2026 | View on SEC |
| 6-K | 8/11/2026 | View on SEC |
| F-X | 8/6/2026 | View on SEC |
| F-10 | 8/6/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | EPRX |
| Company Name | EUPRAXIA PHARMACEUTICALS INC. |
| CIK | 1581178 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | A1 |
| Phone | 250-590-3968 |